Literature DB >> 33800122

Prader-Willi Syndrome and Hypogonadism: A Review Article.

Cees Noordam1,2, Charlotte Höybye3,4, Urs Eiholzer1.   

Abstract

Prader-Labhart-Willi syndrome (PWS) is a rare genetic disorder characterized by intellectual disability, behavioural problems, hypothalamic dysfunction and specific dysmorphisms. Hypothalamic dysfunction causes dysregulation of energy balance and endocrine deficiencies, including hypogonadism. Although hypogonadism is prevalent in males and females with PWS, knowledge about this condition is limited. In this review, we outline the current knowledge on the clinical, biochemical, genetic and histological features of hypogonadism in PWS and its treatment. This was based on current literature and the proceedings and outcomes of the International PWS annual conference held in November 2019. We also present our expert opinion regarding the diagnosis, treatment, care and counselling of children and adults with PWS-associated hypogonadism. Finally, we highlight additional areas of interest related to this topic and make recommendations for future studies.

Entities:  

Keywords:  Prader-Willi syndrome; adult; child; diagnosis; hypogonadism; review; substitution; treatment

Mesh:

Year:  2021        PMID: 33800122      PMCID: PMC7962179          DOI: 10.3390/ijms22052705

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  48 in total

1.  Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group.

Authors:  Carolyn A Bondy
Journal:  J Clin Endocrinol Metab       Date:  2006-10-17       Impact factor: 5.958

2.  Precocious puberty in the male offspring of a mother and daughter with the Prader-Willi syndrome.

Authors:  A Hockey; G Byrne; A Cohen
Journal:  Am J Med Genet       Date:  1987-03

3.  Absence of spermatogonia in the Prader-Willi syndrome.

Authors:  M L Katcher; G J Bargman; E F Gilbert; J M Opitz
Journal:  Eur J Pediatr       Date:  1977-03-18       Impact factor: 3.183

4.  Hypogonadism in females with Prader-Willi syndrome from infancy to adulthood: variable combinations of a primary gonadal defect and hypothalamic dysfunction.

Authors:  Talia Eldar-Geva; Harry J Hirsch; Fortu Benarroch; Orit Rubinstein; Varda Gross-Tsur
Journal:  Eur J Endocrinol       Date:  2009-11-27       Impact factor: 6.664

5.  Genotype-phenotype correlation in a series of 167 deletion and non-deletion patients with Prader-Willi syndrome.

Authors:  G Gillessen-Kaesbach; W Robinson; D Lohmann; S Kaya-Westerloh; E Passarge; B Horsthemke
Journal:  Hum Genet       Date:  1995-12       Impact factor: 4.132

6.  Testosterone replacement therapy to improve secondary sexual characteristics and body composition without adverse behavioral problems in adult male patients with Prader-Willi syndrome: an observational study.

Authors:  Yasuhiro Kido; Satoru Sakazume; Yoshiko Abe; Yuji Oto; Hisashi Itabashi; Masahisa Shiraishi; Atsunori Yoshino; Yuriko Tanaka; Kazuo Obata; Nobuyuki Murakami; Toshiro Nagai
Journal:  Am J Med Genet A       Date:  2013-07-29       Impact factor: 2.802

7.  Central precocious puberty and growth hormone deficiency in a boy with Prader-Willi syndrome.

Authors:  Antonino Crinò; Girolamo Di Giorgio; Riccardo Schiaffini; Alessandra Fierabracci; Sabrina Spera; Andrea Maggioni; Guido Castelli Gattinara
Journal:  Eur J Pediatr       Date:  2008-02-27       Impact factor: 3.183

8.  Testicular histology in boys with Prader-Willi syndrome: fertile or infertile?

Authors:  Annick Vogels; Philippe Moerman; Jean-Pierre Frijns; Guy A Bogaert
Journal:  J Urol       Date:  2008-08-21       Impact factor: 7.450

9.  Improving body composition and physical activity in Prader-Willi Syndrome.

Authors:  Urs Eiholzer; Yves Nordmann; Dagmar l'Allemand; Michael Schlumpf; Silvia Schmid; Katrin Kromeyer-Hauschild
Journal:  J Pediatr       Date:  2003-01       Impact factor: 4.406

10.  Age Distribution, Comorbidities and Risk Factors for Thrombosis in Prader-Willi Syndrome.

Authors:  Merlin G Butler; Aderonke Oyetunji; Ann M Manzardo
Journal:  Genes (Basel)       Date:  2020-01-07       Impact factor: 4.096

View more
  7 in total

Review 1.  Hypothalamic syndrome.

Authors:  Hermann L Müller; Maithé Tauber; Elizabeth A Lawson; Jale Özyurt; Brigitte Bison; Juan-Pedro Martinez-Barbera; Stephanie Puget; Thomas E Merchant; Hanneke M van Santen
Journal:  Nat Rev Dis Primers       Date:  2022-04-21       Impact factor: 52.329

Review 2.  Proteins and proteases of Prader-Willi syndrome: a comprehensive review and perspectives.

Authors:  Sanjukta Basak; Ajoy Basak
Journal:  Biosci Rep       Date:  2022-06-30       Impact factor: 3.976

3.  Inactivating NHLH2 variants cause idiopathic hypogonadotropic hypogonadism and obesity in humans.

Authors:  A Kemal Topaloglu; Enver Simsek; Matthew A Kocher; Jamala Mammadova; Ece Bober; Leman Damla Kotan; Ihsan Turan; Can Celiloglu; Fatih Gurbuz; Bilgin Yuksel; Deborah J Good
Journal:  Hum Genet       Date:  2022-01-23       Impact factor: 5.881

4.  Thyroid function in children with Prader-Willi syndrome in Southern China: a single-center retrospective case series.

Authors:  Xiaojian Mao; Li Liu; Xinjiang Huang; Xi Yin; Dongyan Wu; Yanna Cai; Xiuzhen Li; Wen Zhang; Chunhua Zeng
Journal:  BMC Pediatr       Date:  2022-04-29       Impact factor: 2.567

5.  Single-center real-life experience with testosterone treatment in adult men with Prader-Willi syndrome.

Authors:  Brendan J Nolan; Joseph Proietto; Priya Sumithran
Journal:  Am J Med Genet A       Date:  2022-05-09       Impact factor: 2.578

6.  Prader-Willi Syndrome with Angelman Syndrome in the Offspring.

Authors:  Donatella Greco; Luigi Vetri; Letizia Ragusa; Mirella Vinci; Angelo Gloria; Paola Occhipinti; Angela Antonia Costanzo; Giuseppe Quatrosi; Michele Roccella; Serafino Buono; Corrado Romano
Journal:  Medicina (Kaunas)       Date:  2021-05-08       Impact factor: 2.430

7.  Hypogonadism in Women with Prader-Willi Syndrome-Clinical Recommendations Based on a Dutch Cohort Study, Review of the Literature and an International Expert Panel Discussion.

Authors:  Karlijn Pellikaan; Yassine Ben Brahim; Anna G W Rosenberg; Kirsten Davidse; Christine Poitou; Muriel Coupaye; Anthony P Goldstone; Charlotte Høybye; Tania P Markovic; Graziano Grugni; Antonino Crinò; Assumpta Caixàs; Talia Eldar-Geva; Harry J Hirsch; Varda Gross-Tsur; Merlin G Butler; Jennifer L Miller; Paul-Hugo M van der Kuy; Sjoerd A A van den Berg; Jenny A Visser; Aart J van der Lely; Laura C G de Graaff
Journal:  J Clin Med       Date:  2021-12-10       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.